CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

NEW YORK BLOOD CENTER ENTERPRISES APPOINTS MEGHAN DELANEY, DO, MPH, AS NEXT PRESIDENT & CHIEF EXECUTIVE OFFICER

Neutral
AI Analysis

Summary

New York Blood Center Enterprises appointed Meghan Delaney, DO, MPH, as President and CEO, replacing outgoing CEO Christopher D. Hillyer, MD, who will transition to Special Advisor to the Board.

Importance:2/10
Sentiment:
0.00
management_changeleadership_appointmentexecutive_transition

Read the original article

Published by PR Newswire Biotech on October 12, 2026 8:47 PM

Read Original